/ /

Cheryl Guttman Krader
New technology aims to improve ease, accuracy of toric IOL surgery planning
An enhancement for a proprietary cataract/refractive surgical suite will facilitate and improve astigmatism management with toric IOLs so that surgeons can expect better patient outcomes.
Inlays provide option for presbyopic correction
Three corneal inlays are in clinical use for improving near vision in phakic presbyopic patients with low refractive spherical equivalent.
Risk review supports safety of corneal crosslinking
Severe complications are rare (< 1%) after corneal crosslinking for progressive keratoconus. Some are preventable, some are manageable, but some may lead to a need for corneal transplantation
Glycoprotein and peptide eyedrops promote healing of epithelial defects
Glycoprotein and peptide eyedrops promote healing of epithelial defects
Glycoprotein and peptide eyedrops are effective therapies for non-healing corneal epithelial defects that address underlying causes in the pathophysiology of these lesions.
Algorithm could change way to treat wet AMD
An algorithm for guiding clinical judgments about the futility of anti-VEGF treatment of neovascular age-related macular degeneration (nvAMD) has importance from clinical, ethical, and legal perspectives and would be a valuable decision-making tool for retina specialists and payors, according to David T. Wong, MD.
Multiple strategies pursue treatment of dry AMD
There are a number of ongoing clinical trials investigating treatments for dry age-related macular degeneration (AMD). These modalities include medications that are already in use for other indications and investigational agents representing various novel mechanisms of action.
Case of profound posterior pressure
While participating in an ORBIS Flying Eye Hospital program in Trujillo, Peru, and operating on an elderly patient with a dense cataract under peribulbar anesthesia, James Lehmann, MD, encountered iris prolapse as soon as he made the paracentesis.
SAKURA program reinforces efficacy, safety of intravitreal sirolimus
Results from the Study Assessing double-masKed Uveitis tREAtrement (SAKURA) program support the efficacy and safety of intravitreal sirolimus 440 mcg (Opsiria, Santen) for treating noninfectious uveitis of the posterior segment, said Pauline T. Merrill, MD.
Growing attention turns to cerebrospinal fluid pressure in glaucoma
Recently, evidence has been accumulating to support the theory that cerebrospinal fluid pressure (CSFp) is also important in primary open-angle glaucoma (POAG) and normal-tension glaucoma (NTG), and the relationship has potential implications for clinical practice, said R. Rand Allingham, MD.
ILM removal increases ease, safety of subretinal injections
Removing a small area of internal limiting membrane at the intended site of a subretinal injection allows the injection to be delivered without penetrating the retina.

Poll